Hydroxychloroquine Fails To Prevent COVID-19: Trial
Muhammad Irfan Published June 04, 2020 | 12:44 PM
Hydroxychloroquine, an anti-malaria drug, was not statistically effective in preventing infection for people exposed to the novel coronavirus, a clinical trial showed on Wednesday
CHICAGO, (UrduPoint / Pakistan Point News - 4th Jun, 2020 ) :Hydroxychloroquine, an anti-malaria drug, was not statistically effective in preventing infection for people exposed to the novel coronavirus, a clinical trial showed on Wednesday.
The experiment, led by a team at the University of Minnesota, the United States, in March, was the first randomized clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19, according to the university.
Researchers enrolled 821 adults from the United States and Canada, who had come into contact with someone confirmed with COVID-19 for more than 10 minutes at a distance of six feet (1.83 meters) or less.
All the participants were randomly assigned to receive either hydroxychloroquine, or a vitamin placebo, for five days.
Over the next two weeks, against laboratory test and from clinical signs, researchers found that 49 of the 414, or 11.83 percent, given the medicine got the COVID-19, compared to 58 of the 407, or 14.
25 percent, on the placebo.
The scientists said the difference of about 2.4 percentage points in favor of the medicine was not considered statistically significant, which means hydroxychloroquine has no benefit over placebo in COVID-19 prevention.
Side effects, however, were more common with hydroxychloroquine group than those on the placebo -- 40.1 percent versus 16.8 percent -- no serious ones were reported though.
The trial results has been published in the New England Journal of Medicine.
U.S. President Donald Trump has said he used it as a prophylaxis against COVID-19, but the food and Drug Administration cautioned in late April against the use of it outside of the hospital setting due to the risk of cardiac rhythm problems.
As of 0100 GMT Thursday, confirmed COVID-19 cases have passed 6.3 million globally, with 383,318 deaths, showed the tally of Center for Systems Science and Engineering at Johns Hopkins University.
Related Topics
Recent Stories
Rock-solid Ruud racks up season-leading win in Barcelona
At UN, Iran says it will make Israel 'regret' reprisals
G7 hears calls for 'critical' Ukraine aid
EU seeks to leverage might to confront China, US challenge
5 Customs officials martyred as their vehicle ambushed by terrorists in D I Khan
Pak-New Zealand match called off due to rain
NHA restores traffic on roads affected by recent rains in Balochistan
China to fully support Pakistan's efforts against terrorism: Ambassador Jiang
U.S. envoy calls on Foreign Minister Ishaq Dar
Poland arrests man over suspected plan to kill Zelensky
EU wants to ease youth movement to and from UK
Police foils attempt of supply mainpuri raw material
More Stories From Health
-
DC calls for intensive anti-polio drive in ICT
11 hours ago -
World Hemophilia Day observed to underscore importance of providing comprehensive care
1 day ago -
Six in a family with heart on the 'right side'
1 day ago -
Diabetic disease increasing rapidly : Dr. Noor Elahi Memon
1 day ago -
World Hemophilia Day observed
1 day ago -
ATC dismisses bail petition of doctor involved in illegal kidneys transplant
9 days ago
-
Dr. Shehzad warns against deviation from WHO guidelines on anti-smoking
9 days ago -
Health activists express concerns over attempts to derail tobacco control
11 days ago -
UHS declares MBBS first prof, MS urology exam results
21 days ago -
Increased diagnostic testing for drug resistance
26 days ago -
IRD releases groundbreaking results of end TB programme
28 days ago -
Increased diagnostic testing for drug resistance TB will enhance patients’ treatment outcome
1 month ago